Video

How Renal Function and Comorbidities Affect Dosing for NOACs

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, discusses how a patient's renal function and comorbidities affect dosing regimens for novel oral anticoagulants.

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, discusses how a patient’s renal function and comorbidities affect dosing regimens for novel oral anticoagulants.

This video was recorded at APhA's 2016 Annual Meeting and Exposition in Baltimore, Maryland.

Related Videos
Image credit: JJAVA | stock.adobe.com
Related Content
Mother holding baby's foot with measles spots | Image Credit: © rostock-studio - stock.adobe.com
April 18th 2025

Measles Cases Climb to 800 in United States as Outbreak Spreads Across Borders

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Ozempic Insulin injection pen for diabetics. Concept of losing weight with the drug Image credit: Kassandra | stock.adobe.com
April 18th 2025

Study: Vision Impairment Signals Linked to Semaglutide Use

Kennedy Ferruggia, Assistant Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Allergic asthma airways -- Image credit: Thipphaphone | stock.adobe.com
April 18th 2025

Alternative Methods in Identifying Allergic, Nonallergic Type 2 Asthma Endotypes Are Necessary

Gillian McGovern, Associate Editor
LDL (Bad) lipoprotein (cholesterol) in the blood flow – Closeup view 3d illustration
April 18th 2025

Lepodisiran Reduces Lipoprotein(a) By Nearly 94% in Adults With Elevated Levels of Lp(a)

Luke Halpern, Assistant Editor